(Press-News.org) A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature today.
The analysis represents the first report from Australia's contribution to the International Cancer Genome Consortium (ICGC), which brings together the world's leading scientists to identify the genetic drivers behind 50 different cancer types.
Pancreatic cancer has the highest mortality rate of all the major cancers and is one of the few for which survival has not improved substantially over the past 40 years. It is the fourth-leading cause of cancer death.
Professor Sean Grimmond, from the Institute for Molecular Bioscience (IMB) at The University of Queensland, and Professor Andrew Biankin, from The Kinghorn Cancer Centre at Sydney's Garvan Institute of Medical Research/ St. Vincent's Hospital led an international team of more than 100 researchers that sequenced the genomes of 100 pancreatic tumours and compared them to normal tissue to determine the genetic changes that lead to this cancer.
"We found over 2,000 mutated genes in total, ranging from the KRAS gene, which was mutated in about 90 per cent of samples, to hundreds of gene mutations that were only present in 1 or 2 per cent of tumours," Professor Grimmond said.
"So while tumours may look very similar under the microscope, genetic analysis reveals as many variations in each tumour as there are patients.
"This demonstrates that so-called 'pancreatic cancer' is not one disease, but many, and suggests that people who seemingly have the same cancer might need to be treated quite differently."
Professor Biankin said such individual genetic diagnoses and treatments represent the future of healthcare.
"In this study, we found a set of genes, the axon guidance pathway, that is frequently damaged in pancreatic cancer patients and is associated with a potentially poorer outcome for those patients. It is a new marker of pancreatic cancer that can be used to direct prognoses and treatments.
"'Personalised medicine', where the molecular profile of a patient is matched to the best treatment, is the way the world is moving for many diseases, not just cancer."
"The challenge now will be in moving from population healthcare and a 'one drug fits all' model to personalised healthcare. First we must take the time to develop the necessary genetic knowledge and implement health systems to translate that knowledge effectively."
Professors Biankin and Grimmond acknowledged the vital assistance of the Australian Pancreatic Cancer Genome Initiative, a network of more than 20 hospitals and research institutions Australia-wide, with over 200 members – surgeons, pathologists, nurses and researchers - that all contributed to the project (www.pancreaticcancer.net.au).
They also collaborated with colleagues from the Baylor College of Medicine and The Methodist Hospital Research Institute in Texas, the Ontario Institute for Cancer Research, Johns Hopkins University in Maryland, the University of California San Francisco, the University of Verona, the Cambridge Research Institute and the Sanger Centre in the UK.
The ICGC project is being funded through $27.5 million from the National Health and Medical Research Council of Australia (NH&MRC), its largest-ever single grant.
NHMRC Chief Executive Officer, Professor Warwick Anderson said that "NHMRC is proud to have been the major funding contributor to this research, and I am delighted that breakthroughs have been made in understanding the genetic basis of this disease.
"This positive outcome is evidence of NHMRC supporting the very best research and researchers, and the importance of our involvement in strong national and international collaborations.
"The ultimate goal of our funding is healthier citizens, both in Australia and overseas, and this research will certainly lead to a better understanding of this issue."
### FUNDING
As well as the NHMRC funding, we acknowledge the following additional funding support:
Commonwealth Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); The University of Queensland; Cancer Council NSW; Cancer Institute NSW; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation – INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA).
ABOUT GARVAN
The Garvan Institute of Medical Research was founded in 1963. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with over 600 scientists, students and support staff. Garvan's main research programs are: Cancer, Diabetes & Obesity, Immunology and Inflammation, Osteoporosis and Bone Biology and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.
ABOUT IMB
The Institute for Molecular Bioscience (IMB) is a research institute of The University of Queensland. It was founded in 2000 and aims to improve quality of life by advancing personalised medicine, drug discovery and biotechnology, specifically in the areas of cancer, pain, infection, childhood diseases, obesity, superbugs, diagnostics, agriculture and energy.
All media enquiries should be directed to:
Alison Heather
Science Communications Manager
Garvan Institute of Medical Reseearch
M: + 61 434 071 326
P: +61 2 9295 8128
E: a.heather@garvan.org.au
Professor Sean Grimmond
T: +61 7 3346 2057
M: +61 407 152 857
E: s.grimmond@imb.uq.edu.au
Bronwyn Adams
IMB Communications
T: +61 7 3346 2134
M: +61 418 575 247
E: b.adams@imb.uq.edu.au
Unmasking the deadly secrets of pancreatic cancer
2012-10-25
ELSE PRESS RELEASES FROM THIS DATE:
National Heart Centre Singapore develops world's first human heart cell model
2012-10-25
Researchers at the National Heart Centre Singapore (NHCS) have successfully created a human heart cell model of arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle disorder which puts one at high risk of developing life-threatening arrhythmias and sudden cardiac death. The NHCS research team discovered that key characteristics of the disease, such as abnormal "fatty changes" and altered distribution of proteins involved in cell-cell connections (called desmosomal proteins) are reproduced in the heart cells. This novel cellular model for studying ...
Restricting high-risk individuals from owning guns saves lives
2012-10-25
On July 20, a gunman in Aurora, Colorado, used an assault rifle to murder 12 people and wound 58 others. Although this was one of the worst mass shootings in U.S. history, all mass shootings account for a small percentage of gun violence that occurs in the U.S. every day. In the past 100 days since the Aurora shooting, an estimated 3,035 Americans have died as a result of gun violence.
A new report by researchers at the Johns Hopkins Bloomberg School of Public Health examines policies and initiatives for reducing gun violence in the U.S. by reforming current gun policies. ...
Sensory neurons identified as critical to sense of touch
2012-10-25
DURHAM, N.C. – While studying the sense of touch, scientists at Duke Medicine have pinpointed specific neurons that appear to regulate perception.
The sensory neurons are characterized by thin spikes, and based on their volume, these protrusions determine the cells' sensitivity to force.
The findings in fruit fly larvae, which appear in online Oct. 25, 2012, in the journal Current Biology, demonstrate the first known function for the sensory neurons and provide insights that could broaden the understanding of chronic pain syndromes in humans.
"On a molecular level, ...
Penn-Temple team discovers gatekeeper for maintaining health of cell energy source
2012-10-25
PHILADELPHIA - Most healthy cells rely on a complicated process to produce the fuel ATP. Knowing how ATP is produced by the cell's energy storehouse – the mitochondria -- is important for understanding a cell's normal state, as well as what happens when things go wrong, for example in cancer, cardiovascular disease, neurodegeneration, and many rare disorders of the mitochondria.
Two years ago, Kevin Foskett, PhD, professor of Physiology at the Perelman School of Medicine, University of Pennsylvania, and colleagues discovered that fundamental control of ATP is an ongoing ...
Study reveals genetic causes of a male infertility disorder
2012-10-25
Severe spermatogenic failure (SSF) is a genetic condition that causes low sperm count and infertility. New insights into the genetic alterations that cause this disorder and their prevalence in populations of men around the world are provided by a study published by Cell Press in the American Journal of Human Genetics on October 25. The findings reveal which alterations are the greatest risk factors for the disease, and they could be immediately applicable in genetic counseling for assisted reproduction.
"Medically relevant population genetics studies are well established ...
Anesthesia drugs really do put us to sleep
2012-10-25
When patients are put under anesthesia, they are often told they will be "put to sleep," and now it appears that in some ways that's exactly what the drugs do to the brain. New evidence in mice reported online on October 25 in Current Biology, a Cell Press publication, shows that the drugs don't just turn wakefulness "off," they also force important sleep circuits in the brain "on."
"Despite more than 160 years of continuous use in humans, we still do not understand how anesthetic drugs work to produce the state of general anesthesia," said Max Kelz of the University ...
Stanford researchers develop efficient, protein-based method for creating iPS cells
2012-10-25
STANFORD, Calif. — Coaxing a humble skin cell to become a jack-of-all-trades pluripotent stem cell is feat so remarkable it was honored earlier this month with the Nobel Prize in Physiology or Medicine. Stem cell pioneer Shinya Yamanaka, MD, PhD, showed that using a virus to add just four genes to the skin cell allowed it to become pluripotent, or able to achieve many different developmental fates. But researchers and clinicians have been cautious about promoting potential therapeutic uses for these cells because the insertion of the genes could render the cells cancerous.
Now ...
Genetic tradeoff: Harmful genes are widespread in yeast but hold hidden benefits
2012-10-25
ANN ARBOR— The genes responsible for inherited diseases are clearly bad for us, so why hasn't evolution, over time, weeded them out and eliminated them from the human genome altogether? Part of the reason seems to be that genes that can harm us at one stage of our lives are necessary and beneficial to us at other points in our development.
The idea that the same gene can be both beneficial and harmful, depending on the situation, is called antagonistic pleiotropy. The theory has been around since the 1950s and has been used to explain aging, cancer and genetic diseases.
But ...
Steroid injection linked to increased risk of bone fractures
2012-10-25
DETROIT – Patients treated with an epidural steroid injection for back pain relief are at increased risk of bone fractures in the spine, according to a Henry Ford Hospital study.
Researchers say the risk of fracture increased 29 percent with each steroid injection, a finding they believe raises patient safety concerns.
"For a patient population already at risk for bone fractures, steroid injections carry a greater risk that previously thought and actually pose a hazard to the bone," says Shlomo Mandel, M.D., a Henry Ford orthopedic physician and the study's lead author.
Dr. ...
Male competition over females
2012-10-25
When a female mates with several males, these will compete over the fertilization her eggs. This is an important evolutionary force that has led to the evolution of a diversity of male sexual organ morphologies. This is revealed in a study of seed beetles published today in the leading scientific journal Current Biology.
In higher plants, the influential classification system developed by Carl von Linnaeus relied on the fact that the reproductive parts of plants are evolutionarily stable. This is in sharp contrast to the reproductive organs of animals with internal fertilization, ...